Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TearLab Corporation (TEAR)

0.0931   -0.002 (-2%) 01-18 15:04
Open: 0.10355 Pre. Close: 0.095
High: 0.10355 Low: 0.0931
Volume: 1,199 Market Cap: 1M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.1 - 0.101 0.101 - 0.101
Low: 0.089 - 0.089 0.089 - 0.09
Close: 0.089 - 0.09 0.09 - 0.091

Technical analysis

as of: 2019-01-18 4:36:54 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. It is relatively safe to short or sell, downward move is expected.
Target: Six months: 0.18     One year: 0.20
Support: Support1: 0.08    Support2: 0.03
Resistance: Resistance1: 0.15    Resistance2: 0.18
Pivot: 0.10
Moving Average: MA(5): 0.10     MA(20): 0.10
MA(100): 0.12     MA(250): 0.20
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 30.94     %D(3): 38.69
RSI: RSI(14): 48.87
52-week: High: 0.73  Low: 0.03  Change(%): -76.7
Average Vol(K): 3-Month: 4556  10-Days: 1769

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
TEAR has closed above bottom band by 43.1%. Bollinger Bands are 19.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Midday Gainers / Losers

Nasdaq to delist TearLab tomorrow; shares down 38% premarket

Premarket Losers as of 9:05 am

TearLab tweaks regulatory strategy for inflammatory biomarkers, MMP-9 to be prioritized; shares slip 4%

Tactile Systems: Multiple Near-Term Catalysts For 75% Downside

TearLab (TEAR) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow

HIIQ: Penalties To Exceed $100 Million And Undisclosed "Domino Effect"

TearLab down 20% on expected capital raise and plan to go it alone

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 5.74
Shares Float (M) 0.82
% Held by Insiders 85.70
% Held by Institutions 22.20
Shares Short (K) 625
Shares Short P. Month (K)

Stock Financials

EPS -3.010
EPS Est. Current Year -2.760
EPS Est. Next Year -2.040
EPS Est. Next Quarter -0.620
Forward EPS 1.#IO
Book Value (p.s.) 8.110
PEG Ratio
Profit Margin -60.74
Operating Margin -1.50
Return on Assets (ttm) -63.1
Return on Equity (ttm) 235.9
Qtrly Rev. Growth -5.7
Gross Profit (p.s.) 2.737
Sales Per Share
EBITDA (p.s.) -1.694
Qtrly Earnings Growth
Operating Cash Flow (M) -0.54
Levered Free Cash Flow (M) -2.50

Stock Valuations

P/E -0.03
P/E Growth Ratio -0.15
P/BV 0.01
P/S 381170.28

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-02-27
Last Split Ratio -1e+010
7 Binary Options
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.